Carpe Diem

Tag: hub-tech

Futuristic NIH laboratory using AI and human-cell technology instead of animal testing, featuring organ-on-chip devices and a happy retired lab mouse symbolizing reduced animal experimentation.

🧪 NIH Invests $150M to Replace Animal Testing With Human-Based Research

The NIH just placed a massive bet on the future of medicine: human-based research models that may outperform animal testing while potentially saving animal lives too.

Read entire article

Tags: AI healthcare, animal testing, Carpe Diem, drug development, ethical science, FDA, FUNanc1al health, funanc1al tech, healthcare innovation, hub-health, hub-tech, human-based research, lab testing, medical research, NIH, organ on chip, pharmaceutical research, science news
Chart illustration showing software sector valuations falling from around 40× earnings to roughly 22×, alongside icons representing insider buying and hedge fund positioning shifts.

🧠 Software’s Great Reset — And Why Insiders Are Buying

The North America Software Index has quietly reset, with valuations nearly halving to around 22× earnings. Hedge funds are closing shorts and insiders are buying shares of companies like ServiceNow, CoStar, and The Trade Desk. After one of the sharpest valuation compressions in years, opportunity may be emerging in software.

Read entire article

Tags: AI Stocks, Carpe Diem, Carpe Diem Investing, CoStar, featured-home, Growth Stocks, Hedge Funds, hub-insiders, hub-stocks-fun, hub-tech, Insider Buying, Market Opportunity, ServiceNow, Software Sector, Software Stocks, Stock Market Trends, Tech Stocks, Trade Desk, Valuation Reset